Applied Genetic Technologies Corporation announced the appointment of Stephen W. Potter as its Vice President and Chief Business Officer. In that role he will be responsible for corporate development for the company, including the commercialization of existing product candidates, exploring new opportunities for clinical stage assets, and business development initiatives. Mr. Potter, who has more than 15 years of experience as a senior executive in the biotechnology industry, succeeds Daniel L. Menichella, who resigned from his position at AGTC to pursue another opportunity.

Mr. Potter was employed most recently by NeoStem Inc.